Document 51y41BkLOwmL5bXGB57yrRBD

1st Draft 28/0712005 SYMPOSIUM The Shanghai Health Study: Health Consequences of Exposure to Benzene Leavey Conference Center Georgetown University, Washington, DC 4 November 2005 8:00 - 8:30 Registration and continental breakfast Session 1 Chair: P. Lombardo, University of Virginia (ERP) 8:30 - 9:00 Welcome and Introduction (GU representative; Consortium representative) 9:00 - 9:30 Benzene: What's known and what isn't R. Albertini, Univ of Vermont (SRP) 9:30 -10:00 The Shanghai Health Study: Fudan University and Participating Shanghai Hospitals Hua Fu, Fudan University, Shanghai, China (Co-PI) 10:00 - 10:30 Ethical considerations in the Shanghai Health Study E. Clayton, Vanderbilt University (ERP) 10:30 - 10:45 Coffee Session 2 (Chair: TBO, from SRP) 10:45 - 11 :15 Myelodysplasia and myeloid leukemias: Etiology and gaps in knowledge R. Larson, University of Chicago (SRP) 11: 15 - 11 :30 The Diagnostic Laboratory R. Irons, University of Colorado (Co-PI) 11 :30 - noon The Disease Progression Study: Early findings R. Irons, University of Colorado (Co-PI) 12:00 - 12:30 The Molecular Epidemiology Study TBD 12:30 -1 :30 Lunch 1 SH ELL-MCCLU RG-057835 1st Draft 28/0712005 1:30 - 2:00 2:00 - 2:30 2:30 - 3:00 3:00-3:15 3:15 - 3:45 3:45 - 4:00 4:00-4:15 Session 3 (Chair, TBO, from SRP) Lymphoid neoplasms and the WHO classification: Etiology and gaps in knowledge J. Rice, Georgetown University (SRP) The challenge of exposure assessment T. Armstrong, Exxonfvlobil Corporation (Co-PI) The Hospital-based Case-Control Study O. Wong, Applied Health Sciences, Inc. (Co-PI) Tea Session 4 Chair, H. Greim (SRP) Milestones and future plans R. Schnatter, ExxonMobil Corporation (Co-PI) General Discussion Summary and closure, followed by informal discussions 2 SH ELL-MCCLU RG-OS7836